HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jiannan Feng Selected Research
Jiannan Feng Research Topics
Disease
31
Neoplasms (Cancer)
05/2024 - 05/2003
10
Infections
03/2024 - 01/2009
7
Autoimmune Diseases (Autoimmune Disease)
01/2021 - 04/2006
5
Inflammation (Inflammations)
12/2023 - 01/2018
5
Ovarian Neoplasms (Ovarian Cancer)
11/2017 - 07/2013
5
Rheumatoid Arthritis
01/2016 - 08/2006
4
Breast Neoplasms (Breast Cancer)
11/2021 - 08/2015
4
Multiple Myeloma
08/2019 - 07/2004
4
Neoplasm Metastasis (Metastasis)
08/2019 - 05/2014
3
Hepatocellular Carcinoma (Hepatoma)
12/2023 - 01/2013
3
Lupus Nephritis
03/2023 - 01/2021
3
Poisoning
01/2022 - 07/2015
3
Colitis
01/2019 - 02/2010
3
Crohn Disease (Crohn's Disease)
07/2015 - 08/2006
3
Sepsis (Septicemia)
03/2013 - 10/2010
3
Type 1 Diabetes Mellitus (Autoimmune Diabetes)
02/2010 - 01/2008
2
Virus Diseases (Viral Diseases)
03/2024 - 03/2024
2
Communicable Diseases (Infectious Diseases)
03/2024 - 08/2019
2
Systemic Lupus Erythematosus (Libman-Sacks Disease)
03/2023 - 01/2021
2
Staphylococcal Infections
01/2021 - 05/2008
2
Carcinogenesis
01/2019 - 07/2013
2
Immune System Diseases (Immune Disorders)
01/2017 - 08/2006
2
Carcinoma (Carcinomatosis)
05/2014 - 01/2013
2
Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
02/2010 - 08/2006
1
Chickenpox
03/2024
1
Human Influenza (Influenza)
01/2024
1
Bronchiolitis Obliterans Syndrome
03/2023
1
Albuminuria
03/2023
1
Glioblastoma (Glioblastoma Multiforme)
01/2023
1
Smallpox (Variola)
01/2023
1
Ebola Hemorrhagic Fever
01/2022
1
Triple Negative Breast Neoplasms
11/2021
1
Septic Shock (Toxic Shock Syndrome)
01/2021
1
Hematologic Neoplasms (Hematological Malignancy)
08/2019
1
Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
01/2019
1
Soft Tissue Infections
05/2018
1
Peritonitis
01/2018
Drug/Important Bio-Agent (IBA)
16
Monoclonal Antibodies
IBA
05/2024 - 02/2006
11
Proteins (Proteins, Gene)
FDA Link
01/2022 - 05/2008
8
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2013 - 02/2006
7
Antibodies
IBA
03/2024 - 01/2010
6
Peptides (Polypeptides)
IBA
01/2022 - 07/2004
6
Trastuzumab (Herceptin)
FDA Link
08/2018 - 07/2012
5
Cytokines
IBA
03/2023 - 10/2010
5
Epitopes
IBA
01/2021 - 01/2010
5
Mucin-3
IBA
01/2018 - 02/2010
4
Neutralizing Antibodies
IBA
03/2024 - 01/2009
3
Autoantibodies
IBA
03/2023 - 01/2021
3
Therapeutic Uses
IBA
03/2023 - 01/2008
3
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
11/2021 - 06/2019
3
Ligands
IBA
06/2019 - 12/2012
3
B-Cell Activating Factor
IBA
01/2016 - 08/2006
2
Antigens
IBA
03/2024 - 01/2022
2
ErbB Receptors (EGF Receptor)
IBA
12/2023 - 01/2016
2
Interleukin-2 (IL2)
IBA
03/2023 - 05/2003
2
Immune Checkpoint Inhibitors
IBA
11/2021 - 01/2017
2
Mammaglobin A
IBA
01/2020 - 08/2015
2
Anti-Bacterial Agents (Antibiotics)
IBA
05/2018 - 11/2015
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
11/2017 - 05/2014
2
Bevacizumab (Avastin)
FDA Link
05/2014 - 02/2014
2
Protein Kinases (Protein Kinase)
IBA
09/2013 - 12/2009
2
Interleukin-6 (Interleukin 6)
IBA
09/2006 - 07/2004
1
B7-H1 Antigen
IBA
05/2024
1
Neoplasm Antigens (Tumor Antigens)
IBA
05/2024
1
3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- one
IBA
03/2024
1
Neuraminidase (Sialidase)
IBA
01/2024
1
Membrane Glycoproteins (Membrane Glycoprotein)
IBA
01/2024
1
Hemolysin Proteins (Hemolysins)
IBA
12/2023
1
Anisomycin
IBA
12/2023
1
Mitogen-Activated Protein Kinases
IBA
12/2023
1
Cycloheximide (Cicloheximide)
IBA
12/2023
1
JNK Mitogen-Activated Protein Kinases
IBA
12/2023
1
magrolimab
IBA
06/2023
1
Immunoglobulin G (IgG)
IBA
06/2023
1
Immune Checkpoint Proteins
IBA
06/2023
1
Sirolimus (Rapamycin)
FDA Link
03/2023
1
Chemokines
IBA
03/2023
1
Ubiquitin
IBA
01/2023
1
Deubiquitinating Enzymes
IBA
01/2023
1
Cetuximab (Erbitux)
FDA Link
01/2022
1
Antineoplastic Agents (Antineoplastics)
IBA
01/2022
1
N-Acetylneuraminic Acid (Sialic Acid)
IBA
01/2022
1
Abrin
IBA
01/2022
1
Immunoconjugates (Immunoconjugate)
IBA
11/2021
1
Tyrosine Kinase Inhibitors
IBA
11/2021
1
staphylococcal enterotoxin B
IBA
01/2021
1
pristane (pristan)
IBA
01/2021
1
Exotoxins
IBA
01/2021
1
Polylactic Acid-Polyglycolic Acid Copolymer
IBA
01/2020
1
c-Mer Tyrosine Kinase
IBA
08/2019
1
Axl Receptor Tyrosine Kinase
IBA
06/2019
1
Interferons
IBA
02/2019
1
arsenite
IBA
01/2019
1
Tacrolimus Binding Protein 1A (FKBP12)
IBA
01/2019
1
Macrolides
IBA
05/2018
1
NLR Proteins
IBA
01/2018
1
aluminum sulfate (alum)
IBA
01/2018
Therapy/Procedure
11
Therapeutics
05/2024 - 05/2007
8
Immunotherapy
06/2023 - 05/2003
2
Drug Therapy (Chemotherapy)
11/2021 - 11/2021